Andlauer Healthcare Group Inc. (TSX:AND)
54.97
+0.01 (0.02%)
Inactive · Last trade price on Nov 4, 2025
Andlauer Healthcare Group Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 67.49 | 64.47 | 66.14 | 76.28 | 89.95 | 37.71 |
Depreciation & Amortization | 70.92 | 70.93 | 68.15 | 64.45 | 42.72 | 28.02 |
Stock-Based Compensation | 1.79 | 3.38 | 0.93 | 1.3 | 1.86 | 3.04 |
Other Adjustments | -6.46 | -5.35 | -3.86 | -1.82 | -43.29 | -6.18 |
Change in Receivables | 5.9 | -6.6 | -4.11 | -2.86 | -14.18 | -3.04 |
Changes in Inventories | -0.28 | -3.54 | -2.01 | -0.32 | -0.47 | -0.16 |
Changes in Accounts Payable | -8.07 | 2.27 | -1.01 | 1.49 | 4.45 | -0.95 |
Changes in Income Taxes Payable | -1.42 | -1.2 | -17.66 | -1.72 | 3.18 | -7.18 |
Changes in Other Operating Activities | -1.83 | 0.05 | -2.15 | 0.33 | -0.12 | -0.27 |
Operating Cash Flow | 122.25 | 124.4 | 104.42 | 137.13 | 84.09 | 51 |
Operating Cash Flow Growth | -2.13% | 19.14% | -23.85% | 63.07% | 64.88% | -16.39% |
Capital Expenditures | -19.55 | -17.56 | -23.52 | -25.75 | -8.03 | -4.97 |
Sale of Property, Plant & Equipment | 1.27 | 1.52 | 1.74 | 1.72 | 0.26 | 0 |
Purchases of Intangible Assets | -3.45 | -2.82 | -2.07 | -2.21 | -1.64 | -0.47 |
Purchases of Investments | - | - | - | - | -7.65 | - |
Payments for Business Acquisitions | - | - | - | -19.32 | -166.32 | -14.93 |
Investing Cash Flow | -27.86 | -18.86 | -23.85 | -45.56 | -183.38 | -20.37 |
Short-Term Debt Issued | - | 40 | - | 12 | 50 | - |
Short-Term Debt Repaid | - | -10 | - | -23 | -39 | -3.93 |
Net Short-Term Debt Issued (Repaid) | - | 30 | - | -11 | 11 | -3.93 |
Long-Term Debt Issued | - | - | - | - | 25 | - |
Long-Term Debt Repaid | -33.16 | -31.04 | -52.95 | -29.03 | -25.11 | -20.74 |
Net Long-Term Debt Issued (Repaid) | -33.16 | -31.04 | -52.95 | -29.03 | -0.11 | -20.74 |
Issuance of Common Stock | - | - | - | - | 97.05 | - |
Repurchase of Common Stock | -14.6 | -106.67 | -18.84 | - | - | - |
Net Common Stock Issued (Repurchased) | -14.6 | -106.67 | -18.84 | - | 97.05 | - |
Common Dividends Paid | -18.04 | -16.72 | -14.2 | -10.88 | -7.85 | -7.93 |
Other Financing Activities | -0.23 | -1.8 | -0.19 | -0.67 | -6.2 | 13.4 |
Financing Cash Flow | -76.02 | -126.24 | -86.18 | -51.59 | 93.89 | -19.2 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.12 | 1.44 | -0.5 | 0.88 | 0.24 | - |
Net Cash Flow | 18.25 | -20.7 | -5.61 | 40.87 | -5.16 | 11.44 |
Beginning Cash & Cash Equivalents | 40.73 | 59.74 | 65.86 | 24.99 | 30.15 | 18.71 |
Ending Cash & Cash Equivalents | 58.98 | 40.48 | 59.74 | 65.86 | 24.99 | 30.15 |
Free Cash Flow | 102.7 | 106.84 | 80.9 | 111.38 | 76.07 | 46.04 |
Free Cash Flow Growth | -3.88% | 32.07% | -27.37% | 46.43% | 65.23% | -16.40% |
FCF Margin | 15.79% | 16.43% | 12.48% | 17.18% | 17.28% | 14.65% |
Free Cash Flow Per Share | 2.58 | 2.61 | 1.90 | 2.61 | 1.90 | 1.20 |
Levered Free Cash Flow | 74.1 | 114.37 | 34.98 | 74.72 | 142.57 | 27.55 |
Unlevered Free Cash Flow | 107.84 | 119.63 | 91.91 | 119.6 | 102.86 | 55.74 |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.